Novartis Contract Manufacturing Capacity Update October 2025: Large Molecule

Novartis Contract Manufacturing is a leading global CDMO, specializing in biotech, small molecules, cell & gene therapy, and fill & finish. With over 40 years of GMP experience in contract manufacturing and a network of more than 20 manufacturing sites worldwide, we are committed to meeting our clients' evolving needs, building long-lasting CDMO partnerships based on trust and excellence.

In this session, Novartis Contract Manufacturing presents an overview of Large Molecules manufacturing solutions and available production capacities. Gain insight into our global manufacturing network, including information about the capabilities of each mammalian and microbial site within the network.